The report "North America Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030" is projected to grow from USD 2.98 billion in 2025 and to reach USD 4.64 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Browse 150 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on "North America Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030"
View detailed Table of Content here -https://www.marketsandmarkets.com/Market-Reports/north-america-nucleic-acid-isolation-purification-market-63577630.html
Several factors are driving the growth of the North America nucleic acid isolation and purification market. One significant driver is the region's extensive network of hospital laboratories, reference laboratories, and public health laboratories that conduct a high volume of PCR and NAAT tests. This creates strong demand for DNA and RNA extraction kits, magnetic beads, columns, and cleanup buffers. Additionally, laboratories are increasingly adopting more consistent and automation-ready extraction workflows due to the growing use of NGS in clinical testing.
In 2024, the kits segment accounted for the dominant share of the North America nucleic acid isolation and purification market, by product.
Based on product, the nucleic acid isolation and purification market in North America is divided into kits, reagents, and instruments. In 2024, the kits segment held the largest revenue share in the North America nucleic acid isolation and purification market. This reflects how extraction is kit-led and repeat-purchase driven across routine workflows. Magnetic bead kits and spin-column kits are purchased continuously because labs process samples daily for PCR and NGS. Viral RNA and cfDNA/low-input kits further increase spending due to stringent performance requirements. Kits also simplify standardization and validation, especially in multi-site hospital and reference lab networks. As a result, recurring kit demand remains central across hospitals and diagnostic centers, public health labs, research institutes, and CRO/CDMO labs in the region.
The hospitals & diagnostic centers segment dominated the market in 2024.
By?????? end user, the market has been segmented into hospitals & diagnostic centers, academic & government research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. Hospitals & diagnostic centers held the largest share in 2024, mainly due to their high daily volumes of molecular testing. In these settings, DNA/RNA extraction is a mandatory first step for PCR/NAAT assays and many sequencing-based tests. As a result, large quantities of extraction kits (magnetic beads and columns), reagents, and disposable plastics are purchased on a recurring basis.
The US is expected to grow at the highest rate in the North America nucleic acid isolation and purification market during the forecast period.
By country, the North America nucleic acid isolation and purification market is divided into the US and Canada. The US is the largest market due to the large number of hospital labs, reference labs, and public health networks that run high volumes of PCR/NAAT testing. Additionally, the US is a leader in the clinical and research applications of NGS, necessitating uniform, automated, and efficient extraction workflows.
Key companies active in the North America nucleic acid isolation and purification market include Thermo Fisher Scientific (US), Danaher (US), QIAGEN (Germany), F. Hoffman-La Roche (Switzerland), and Agilent Technologies, Inc. (US), along with other regional and global companies.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/